Seeking Alpha
 

McKesson Corporation (MCK)

- NYSE
  • May. 7, 2013, 12:10 AM
    Notable earnings after Tuesday’s close: ANDE, ARAY, AWK, AXLL, BIO, BIOL, BMC, BWC, CA, CDXS, CHRW, CODI, DGI, DGIT, DIS, DVA, EA, ENPH, EXEL, GA, GPOR, HTA, IAG, JAZZ, KGC, LYV, MAKO, MCEP, MCK, MDLZ, MITK, MRO, MYGN, NVTL, OAS, OCLR, OHI, ONXX, ORA, PRI, RBCN, SD, SGEN, SYMC, SYNC, TRIP, TWO, URS, VCLK, WBMD, WFM, WMB, WPZ, WTI, Z
    | 1 Comment
  • May. 6, 2013, 5:35 PM
    Notable earnings after Tuesday’s close: ANDE, ARAY, AWK, AXLL, BIO, BIOL, BMC, BWC, CA, CDXS, CHRW, CODI, DGI, DGIT, DIS, DVA, EA, ENPH, EXEL, GTEK, GA, GPOR, IAG, JAZZ, KGC, LYV, MAKO, MCEP, MCK, MDLZ, MITK, MRO, MYGN, NVTL, OAS, OCLR, OHI, ONXX, ORA, PRI, RBCN, SD, SGEN, SYMC, SYNC, TRIP, TWO, URS, VCLK, WBMD, WFM, WMB, WPZ, WTI, Z
    | 1 Comment
  • May. 4, 2013, 3:52 PM
    Barron's is out with its list of the 500 financially strongest companies as ranked after a rigorous cash and sales analysis. A quick filter on the list shows a good chunk of the names trade with a single-digit price to earnings ratio including Goodyear Tire & Rubber (GT). Despite all the buzz about booming auto sales in the U.S. and China, concerns about growth for Goodyear's products in other regions of the globe have lowered expectations. But with auto sale estimates for full-year being taken higher, Goodyear could see enough consistent revenue growth to justify a higher trading multiple. (Top 25: AAPL, WCC, WDC, DVA, CHRW, QCOM, JOY, V, STX, MRC, MA, CVI, COF, SYMC, MCK, WCG, ETN, BRCM, TMO, CI, CBI, NOV, WNR, HFC, DK)
    | 39 Comments
  • Mar. 19, 2013, 10:47 AM
    Another casualty of the Walgreen-AmerisourceBergen deal may be McKesson (MCK -4.1%) with Walgreen currently using the company's prescription medication dispensing system.
    | Comment!
  • Jan. 31, 2013, 4:28 PM
    More on McKesson (MCK): FQ3 misses on the bottom line while beating total sales estimates, driven by higher medical-surgical distribution and services revenues. For FY13, EPS estimates are guided lower, now expected to be between $7.15 - 7.35 to $7.10 - 7.30 per share. Street estimates are for an EPS of $7.30. The company also says it's board has authorized an additional $500M to its stock buyback program. Shares -2.6% AH.
    | Comment!
  • Jan. 31, 2013, 4:16 PM
    McKesson (MCK): Q4 EPS of $1.41 misses by $0.22. Revenue of $31.2B (+1% Y/Y) beats by $400M. Shares -4.9% AH. (PR)
    | 1 Comment
  • Jan. 31, 2013, 12:10 AM
    Notable earnings after Thursday’s close: AFFX, BCR, BKH, CAVM, CB, CTCT, CTRP, ED, EMN, FBHS, GDOT, MCK, MIPS, MITK, MTW, N, NGVC, PFG, PMCS, PWER, SPF, TLAB, TSYS, WYNN, ZOLT
    | Comment!
  • Jan. 30, 2013, 6:20 PM
    McKesson Corporation (MCK) declares $0.20/share quarterly dividend, in line with previous. Forward yield 0.76%. For shareholders of record Mar. 01. Payable Apr. 01. Ex-div date Feb. 27. (PR)
    | Comment!
  • Jan. 30, 2013, 5:35 PM
    Notable earnings after Thursday’s close: AFFX, BCR, BKH, CAVM, CB, CTCT, CTRP, ED, EMN, FBHS, GDOT, MCK, MIPS, MITK, MTW, N, NGVC, PFG, PMCS, PWER, SPF, TLAB, TSYS, WYNN, ZOLT
    | Comment!
  • Jan. 3, 2013, 12:40 PM
    Cowen names McKesson (MCK +0.8%) as a Top Distributor pick, saying that recent acquisitions such as PSS World Medical, share repurchases and strong relative earnings growth leave the company in a strong position going forward. The firm reiterates an Outperform on the shares.
    | Comment!
  • Dec. 26, 2012, 2:04 PM
    McKesson (MCK -1.2%) says it's received notification of early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act in connection with its proposed acquisition of PSS World Medical (PSSI +1.3%). The termination of the waiting period is just one of the obstacles it needs to hurdle in it's proposed acquisition of PSS World Medical.
    | Comment!
  • Dec. 19, 2012, 4:40 PM
    GlaxoSmithKline (GSK) reaches a $150M preliminary settlement with U.S. drug wholesalers claiming the company improperly delayed the market entry of competitive generic alternatives to its nasal spray Flonase. The settlement was reached with AmerisourceBergen (ABC), Cardinal Health (CAH), and McKesson (MCK), among others, who maintained that GSK had abused the citizen's petition process to monopolize the market and overcharge for the spray by restricting access to less expensive generic versions.
    | 1 Comment
  • Dec. 17, 2012, 5:51 PM
    McKesson (MCK) says it's been awarded a contract for up to $2.61B from the U.S. Department of Defense for delivery of mail order pharmaceutical products. The contract will run through June, 2015.
    | Comment!
  • Dec. 6, 2012, 9:06 AM
    Aetna's (AET) cancer-management program, which it's carrying out with the U.S. Oncology Network and a McKesson (MCK) unit, had a positive impact on patients and helped to cut costs. The scheme cut ER visits 39.8%, hospital admissions 16.5% and the number of hospital days 35.9%. The scheme led to 12% cost savings among lung, breast and colorectal cancers alone. (PR)
    | 1 Comment
  • Oct. 26, 2012, 5:40 PM
    McKesson (MCK) declares $0.20/share quarterly dividend, in line with previous. Forward yield 0.86%. For shareholders of record Dec 03. Payable Jan 02. Ex-div date Nov 29. Shares +0.5% AH. (PR)
    | Comment!
  • Oct. 25, 2012, 11:36 AM
    Shares of athenahealth (ATHN -2.1%) dip on the back of today's earlier announcement that PSS Worldwide (PSSI +33%) had agreed to be acquired by McKesson (MCK +4%). PSSI currently sells ATHN's services to physicians, and investors appear to be concerned that the relationship is likely to be derailed over the long-term, despite MCK's assertion that it doesn't plan to immediately "distort or dismantle" any of PSS's relationships "without careful evaluation."
    | Comment!
Visit Seeking Alpha's
MCK vs. ETF Alternatives
Company Description
McKesson Corporation distributes pharmaceuticals, medical supplies and healthcare information technology that make healthcare safer while reducing costs.
Sector: Services
Industry: Drugs Wholesale
Country: United States